The global medical aesthetics market hit $28.49 billion in 2025 and is on track to reach $31.96 billion in 2026, with procedure volume growing 42.5% over the past four years. Plastic surgeons performed more than 37.5 million aesthetic procedures worldwide in 2024, including 7.8 million botulinum toxin treatments. This article covers market size, procedure volumes, regional breakdowns, and product segment data through 2034.
Key Aesthetic Medicine Market Statistics
- The global medical aesthetics market reached $28.49 billion in 2025 and will grow to $89.59 billion by 2034 at a 13.75% CAGR.
- Plastic surgeons performed 37.5 million aesthetic procedures globally in 2024, a 42.5% jump from 2020.
- Botulinum toxin remained the top non-surgical procedure with 7.8 million treatments in 2024.
- North America held 54.87% of the global market in 2025 at $15.63 billion.
- Eyelid surgery overtook liposuction as the most common surgical procedure for the first time on record.
Aesthetic Medicine Market Size and Growth Forecast
The medical aesthetics market grew from $28.49 billion in 2025 to a projected $31.96 billion in 2026, according to Fortune Business Insights. The forecast extends to $89.59 billion by 2034 at a 13.75% compound annual growth rate.
Different research firms report varying figures based on what they include. Roots Analysis values the market at $37.6 billion in 2024 because its scope covers a broader set of devices and products. The variance comes down to scope, not disagreement on the underlying trend.
| Research Firm | Base Value | Forecast End | CAGR |
|---|---|---|---|
| Fortune Business Insights | $28.49B (2025) | $89.59B (2034) | 13.75% |
| Roots Analysis | $37.6B (2024) | $102.3B (2035) | 9.6% |
| SkyQuest | $19.73B (2024) | $55.15B (2033) | 12.1% |
| Facial injectable sub-segment | $12.53B (2024) | $24.9B (2030) | 12.3% |
| US aesthetic injectable | $4.1B (2024) | — | 11.2% |
Source: Fortune Business Insights, Roots Analysis, SkyQuest, Grand View Research
How Many Aesthetic Procedures Are Performed Globally?
The International Society of Aesthetic Plastic Surgery (ISAPS) recorded 17 million surgical and 20.5 million non-surgical aesthetic procedures performed by plastic surgeons in 2024. The total of 37.5 million procedures reflects a 42.5% rise since 2020.
Botulinum toxin topped the non-surgical list with 7.8 million procedures. Hyaluronic acid filler procedures reached 6.3 million, up 5.2% year over year. Together these two treatments make up about 70% of all non-surgical procedures tracked by plastic surgeons.
ISAPS Procedure Data by Year
| Metric | 2023 | 2024 | YoY Change |
|---|---|---|---|
| Total procedures | 34.9 million | 37.5 million | +7.5% |
| Surgical procedures | 15.8 million | 17 million+ | +7.6% |
| Non-surgical procedures | 19.1 million | 20.5 million+ | +7.3% |
| Botulinum toxin (#1 non-surgical) | — | 7.8 million | — |
| Hyaluronic acid fillers | — | 6.3 million | +5.2% |
| 4-year change (2020–2024) | — | +42.5% | — |
Source: ISAPS Global Survey 2024, released June 19, 2025
Eyelid surgery displaced liposuction as the most common surgical procedure in 2024. ISAPS flagged this as the first such category change on record after liposuction held the top position for at least 13 consecutive years.
Aesthetic Medicine Market Statistics by Region
North America accounted for $15.63 billion in 2025, or 54.87% of the global medical aesthetics market. The region will reach $17.73 billion in 2026, with the United States alone valued at $16.27 billion. Galderma and other major aesthetics suppliers report North America as their largest revenue source.
Europe sat at $5.40 billion in 2025 (18.97% share). Asia Pacific came in close behind at $5.36 billion (18.81%). Latin America held 4.40% and Middle East & Africa 2.95%.
| Region / Country | 2025 Value | 2026 Projected | Global Share (2025) |
|---|---|---|---|
| North America | $15.63 billion | $17.73 billion | 54.87% |
| Europe | $5.40 billion | $5.95 billion | 18.97% |
| Asia Pacific | $5.36 billion | $6.03 billion | 18.81% |
| Latin America | $1.25 billion | $1.36 billion | 4.40% |
| Middle East & Africa | $0.84 billion | $0.89 billion | 2.95% |
Source: Fortune Business Insights, 2025
Top Country Markets
| Country | 2026 Projected Value |
|---|---|
| United States | $16.27 billion |
| China | $1.76 billion |
| Japan | $1.36 billion |
| Germany | $1.33 billion |
| United Kingdom | $1.08 billion |
| India | $0.70 billion |
Source: Fortune Business Insights, 2025
The US recorded 6.1 million plastic surgeon-performed procedures in 2024, the highest country volume worldwide. Brazil came second with 3.1 million procedures and led globally in surgical volume at 2.3 million procedures.
Aesthetic Medicine Market by Product Segment
Non-energy-based devices, which include injectables, will hold 62.42% of the global market in 2026. Energy-based devices accounted for 31.7% as of 2023. Skin resurfacing and tightening applications represent 44.16% of the 2026 market.
Botulinum toxin held 53.28% of the global facial injectable market in 2024, while it captured 45.9% of the US aesthetic injectable market. Hyaluronic acid fillers made up roughly 25% of all non-surgical procedures.
End-User Distribution
Specialty clinics commanded 40.49% of the global medical aesthetics market in 2026 projections. MedSpas represented 47.0% of the US injectable market and 46.9% globally. The shift away from hospital settings toward purpose-built aesthetic venues continues across major markets.
| Segment | Market Share | Period |
|---|---|---|
| Non-energy-based devices | 62.42% | 2026 projected |
| Energy-based devices | 31.7% | 2023 base |
| Skin resurfacing & tightening | 44.16% | 2026 projected |
| Specialty clinics (end-user) | 40.49% | 2026 projected |
| MedSpa (US injectable end-user) | 47.0% | 2024 |
| Botulinum toxin (facial injectable) | 53.28% | 2024 |
Source: Fortune Business Insights, Grand View Research
Where Is the Aesthetic Medicine Market Growing Fastest?
Asia Pacific posts a 16% CAGR in the facial injectable market through 2030, more than triple North America’s pace. South Korean aesthetic innovation exports and rising HA filler adoption across China, Japan, India, and Thailand drive this growth.
India and China together represent $2.46 billion in 2026 projections. ISAPS named Asia the “center of growth” in its 2024 survey commentary. AbbVie’s Allergan Aesthetics division, which sells Botox and Juvederm, reported $5.2 billion in 2023 revenue, with Botox alone exceeding $5.6 billion in worldwide sales.
| Market | CAGR | Period |
|---|---|---|
| Asia-Pacific facial injectable | 16.0% | 2025–2030 |
| Global facial injectable | 12.3% | 2025–2030 |
| US aesthetic injectable | 11.2% | 2025–2030 |
| Dermal fillers (global) | 10.3% | 2024–2033 |
| Asia-Pacific medical aesthetics (broad) | 5.06% | 2025–2032 |
Source: Grand View Research, SkyQuest
FAQs
How big is the global aesthetic medicine market?
The global medical aesthetics market reached $28.49 billion in 2025 and will hit $31.96 billion in 2026, according to Fortune Business Insights. The market is projected to grow to $89.59 billion by 2034 at a 13.75% compound annual growth rate.
How many aesthetic procedures are performed each year?
Plastic surgeons performed 37.5 million aesthetic procedures globally in 2024, including 17 million surgical and 20.5 million non-surgical treatments. Procedure volume rose 42.5% from 2020 to 2024 according to the ISAPS Global Survey.
What is the most popular non-surgical aesthetic procedure?
Botulinum toxin remained the top non-surgical procedure in 2024 with 7.8 million treatments worldwide. Hyaluronic acid fillers came second at 6.3 million procedures, up 5.2% from the prior year.
Which region leads the aesthetic medicine market?
North America led with 54.87% of the global market in 2025 at $15.63 billion. The United States alone is valued at $16.27 billion in 2026 and recorded 6.1 million plastic surgeon-performed procedures in 2024.
What is the fastest-growing aesthetic medicine market?
Asia-Pacific is the fastest-growing facial injectable market with a 16% CAGR through 2030. China leads the region at $1.76 billion in 2026 projections, followed by Japan at $1.36 billion and India at $0.70 billion.
